EPISODE · Aug 12, 2024 · 37 MIN
Engineering Dendritic Cells to Treat Cancer (Part 2) | Guardian Bio
from Nucleate Podcast · host Ananya Zutshi, Sam Kessel, Ricky Barrett
Part 2Using TikTok to develop scientific communication skills [0:00]Advice for entrepreneurs starting a company [6:00]Guardian's Series A Fundraise and how they are navigating VC Fundraising [10:30]The long-term vision of Guardian Bio for novel cell therapies treating [14:30]The importance of Diversity in Biotech [17:20]Exciting trends in Biotech that Ananya and Ricky are following [25:40]Passions outside of biotech and staying centered with a busy career [30:30]
Embed this episode
What this episode covers
In this episode of the Nucleate Podcast, we are joined by Ananya Zutshi and Ricky Barrett, founders of Guardian Bio, a Boston-based biotech company (and Nucleate Alumni). Their platform focuses on engineering dendritic cells to target solid tumors. We delve into the ups and downs of their entrepreneurial journey, the unique dynamic between co-founders, and their advice for communicating complex science topics.
Ready to play
Engineering Dendritic Cells to Treat Cancer (Part 2) | Guardian Bio
No transcript for this episode yet
Similar Episodes
Similar Podcasts
No similar podcasts found.